European Primary Care Cardiovascular Society
EPCCS Annual CV Summit

Update on managing CV risk in diabetes: what's the evidence?

5' education - Mar. 22, 2019 - Lisbon, Portugal - Kamlesh Khunti & Richard Hobbs
EPCCS Annual CV Summit

Stroke prevention in atrial fibrillation

5' education - Mar. 21, 2019 - Lisbon, Portugal - Michaela Machácová & Richard Hobbs
EPCCS Annual CV Summit

Recent updates to the international Hypertension Guidelines - where do they vary and what should we agree in primary care?

5' education - Mar. 21, 2019 - Lisbon, Portugal - Richard McManus & Richard Hobbs
EPCCS Annual CV Summit

Multimorbidity, CV disease and polypharmacy

10' education - Mar. 21, 2019 - Lisbon, Portugal - Dr. David Silvério Rodrigues

Lifestyle improvement forms the basis of comprehensive ACC/AHA guideline for primary prevention

3' education - Mar. 20, 2019 - New Orleans, LA, USA - Dr. Amit Khera

Implementation of advice facilitated by new overarching recommendations in ACC/AHA primary prevention guideline

3' education - Mar. 20, 2019 - New Orleans, LA, USA - Donna Arnett, MD

84% True AF in those with irregular pulse detected with smartwatch in proof-of-concept study

3' education - Mar. 20, 2019 - New Orleans, LA, USA - Michael Valentine, MD

First ischemic events and recurrent events reduced with highly purified omega-3 fatty acid

3' education - Mar. 20, 2019 - New Orleans, LA, USA - Deepak L. Bhatt, MD

ESC/ESH Guidelines on management of hypertension: what's new?

3' education - Feb. 11, 2019 - Prof. Bryan Williams - London, UK

EPCCS

3' education - Feb. 8, 2019

EPCCS society: what is available for members?

3' education - Feb. 7, 2019 - Prof. Richard Hobbs, MD

May Measurement Month: Get involved to increase awareness on elevated blood pressure

3' education - Feb. 6, 2019 - Prof. Neil Poulter - London, UK

Primary prevention of CV events with aspirin: yes or no?

3' education - Jan. 31, 2019 - Prof. dr. Freek Verheugt - Amsterdam, The Netherlands

HFpEF: What is it & size of the problem

10' education - Aug. 27, 2018 - Prof. Adriaan Voors - Groningen, The Netherlands

HFpEF: Current and future clinical approaches to manage HFpEF

10' education - Aug. 27, 2018 - Burkert Pieske, MD - Berlin, Germany

HFpEF: What are the most likely pathophysiological mechanisms involved in the disease

10' education - Aug. 27, 2018 - Carolyn Lam, MD - Singapore

HFpEF: How to diagnose

10' education - Aug. 27, 2018 - Barry Borlaug - Rochester, MN, USA

Primary Cardiovascular Care in Spain (Spanish)

5' education - Jan. 10, 2019 - EPCCS Council Berlin - Francisco Javier Sanz Garcia

Primary Cardiovascular Care in Spain (English)

5' education - Jan. 10, 2019 - EPCCS Council Berlin - Francisco Javier Sanz Garcia

The cardiovascular challenge for primary care in diabetes

10' education - July 10, 2018 - Prof. Richard Hobbs - Oxford, UK

Update on managing CV risk in diabetes: what's the evidence?

5' education - Mar. 22, 2019 - Lisbon, Portugal - Kamlesh Khunti & Richard Hobbs
Profs Khunti and Hobbs discuss why CV risk needs attention in patients with diabetes, and how this risk can be mitigated. They also consider barriers that prevent optimal implementation of the evidence on effective management strategies.

EPCCS 2019 Profs Khunti and Hobbs discuss why CV risk needs attention in patients with diabetes, and how this can be mitigated. They also consider barriers that prevent optimal implementation of the evidence on effective management strategies.

Benefit of intensive BP lowering in adults with diabetes seems independent of baseline BP

Literature - May 20, 2019 - Rahman F T et al.. - Hypertension. 2019

An analysis of the ADVANCE study shows that the treatment effect of perindopril-indapamide in patients with diabetes is independent of SBP, DBP or 10-year ASCVD risk at baseline.

Stroke prevention in atrial fibrillation

5' education - Mar. 21, 2019 - Lisbon, Portugal - Michaela Machácová & Richard Hobbs
Dr. Machácová and prof. Hobbs discuss steps of management of patients with atrial fibrillation, from identification to treatment to lower the associated stroke risk, including best practice when optimal options are unavailable.

EPCCS 2019 Dr. Machácová and prof. Hobbs discuss steps of management of patients with atrial fibrillation, from identification to treatment to lower the associated stroke risk, including best practice when optimal options are unavailable.

Consumption of low-carbohydrate diets results in higher risk of all-cause and cause-specific mortality

Literature - May 6, 2019 - Mazidi M et al. - Eur Heart J 2019

Consumption of low-carbohydrate diets was associated with higher risk of all-cause, CHD, cerebrovascular and cancer mortality in adults, as shown in analyses based on individual and on pooled data.

The mortality risk associated with sedentary behavior can be offset by much physical activity

Literature - May 2, 2019 - Stamatakis E et al., - J Am Coll Cardiol. 2019
Comprehensive joint and stratified analyses on sitting, physical activity and all-cause or CV mortality risk evaluated the effects of replacing sitting with various physical activity patterns on mortality risk.

Comprehensive joint and stratified analyses on sitting, physical activity and all-cause or CV mortality risk evaluated the effects of replacing sitting with various physical activity patterns on mortality risk. With poll.

Signs of oral infections in childhood linked to subclinical carotid atherosclerosis in adulthood

Literature - Apr. 30, 2019 - Pussinen PJ et al. - JAMA Netw Open. 2019

Bleeding on probing, increased probing pocket depth, caries or fillings in childhood were associated with increased IMT 27 years later, independent of cumulative exposure to CV risk factors.

Women with history of frequent whole-blood donation show lower CV morbidity

Literature - Apr. 29, 2019 - Peffer K et al - Heart 2019

In a study that aimed to address the healthy donor effect, women who had frequently donated blood in the first 10 years of their donation career, showed fewer CV events than those less often donating.

Higher CVD risk with sub-optimal LDL-c lowering in many patients initiating statin therapy

Literature - Apr. 29, 2019 - Akyea RK et al. - Heart 2019

In a primary care patient cohort, >50% of patients initiating statin therapy did not show optimal LDL-c lowering, which significantly increased their risk of future CVD events.

Education, exchange, guidance and interaction during EPCCS Summit 2019

EPCCS Annual CV Summit

EPCCS 2019 Read impressions of the updates on stroke prevention in AF, hypertension, HF and CV risk in diabetes, with emphasis on challenges faced in patients with multimorbidities.

Recent updates to the international Hypertension Guidelines - where do they vary and what should we agree in primary care?

5' education - Mar. 21, 2019 - Lisbon, Portugal - Richard McManus & Richard Hobbs
Profs. McManus and Hobbs consider the latest recommendations and insights on how to diagnose elevated blood pressure and when to initiate treatment.

Profs. McManus and Hobbs consider the latest recommendations and insights on how to diagnose elevated blood pressure and when to initiate treatment.

Multimorbidity, CV disease and polypharmacy

10' education - Mar. 21, 2019 - Lisbon, Portugal - Dr. David Silvério Rodrigues
Dr. Rodrigues zooms in on an individual patient case to illustrate the complexity of management of patients with multimorbidity and polypharmacy.

EPCCS 2019 Dr. Rodrigues zooms in on an individual patient case to illustrate the complexity of management of patients with multimorbidity and polypharmacy.

Increased risk of incident CVD and mortality with higher consumption of dietary cholesterol or eggs

Literature - Apr. 4, 2019 - Zhong VW et al. - JAMA 2019
Among US adults, higher consumption of dietary cholesterol or eggs was significantly associated with higher risk of incident CVD and all-cause mortality in a dose-response manner.

Among US adults, higher consumption of dietary cholesterol or eggs was significantly associated with higher risk of incident CVD and all-cause mortality in a dose-response manner.